Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRISS: Ivabradine for Heart Rate Control in Septic Shock
2024-515019-22-00Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ivabradine in septic shock (3 arms), sponsored by Assistance publique - Hôpitaux de Paris. Started Dec 2024; status: completed.
02
Drugs
ivabradine
03
Conditions
septic shock
Beyond the preview
Go deeper on 2024-515019-22-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515019-22-00.